AU Patent

AU2020234961C1 — Charged ion channel blockers and methods for use

Assigned to Nocion Therapeutics Inc · Expires 2025-08-14 · 1y expired

What this patent protects

The invention provides compounds of Formula (I), or pharmaceutically acceptable salts thereof: (I) The compounds, compositions, methods and kits of the invention are useful for the treatment of pain, itch, and neurogenic inflammation.

USPTO Abstract

The invention provides compounds of Formula (I), or pharmaceutically acceptable salts thereof: (I) The compounds, compositions, methods and kits of the invention are useful for the treatment of pain, itch, and neurogenic inflammation.

Drugs covered by this patent

Patent Metadata

Patent number
AU2020234961C1
Jurisdiction
AU
Classification
Expires
2025-08-14
Drug substance claim
No
Drug product claim
No
Assignee
Nocion Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.